Novartis AG
Aminopyridine derivatives and their use as selective ALK-2 inhibitors

Abstract:

The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form (I) to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva. ##STR00001##